Navigation Links
Amazing Treatment Relieves Serious Back Pain Without Dangerous Drugs, Injections or Surgery!
Date:12/14/2007

e patients who have given up hope of ever being pain free. I believe this treatment will become as common in the treatment of back pain as laser eye surgery has become as a treatment for nearsightedness."

Dr. Thea Flock makes for a great interview and can be reached at 630-771-9662.

For further information contact: Dr. Thea Flock, 630-771-9662

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Flock Spinal Center, S.C.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
8. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
9. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
10. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
11. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...poricidin disinfectant solution and wipes are reli...ainst H1N1 and Influenza A., , ... Contec Inc, the leading manufacturer of clean ro... disinfectants have been deemed by the EPA as eff...Pandemic 2009 H1N1 influenza A virus (the swine fl...
(Date:11/23/2009)...re/--PearlTherapeuticsInc.,abiopharmaceuticalcompa...ronicrespiratorydiseases,todayannouncedtheappointm...osenhas25yearsofexperienceinthepharmaceuticalandbi...encesandALZACorporation.Hisappointmentincreasesthe...bringsawealthofproductdevelopment,commercializatio...
(Date:11/20/2009)... -- Veridiam (www.veridiam.com) won the prestigiou...t the 2009 Workplace Excellence Awards. The awards...Resources Management and recognize innovative and ...iam was one of nine winners, selected from more th...e recent awards ceremony. San Diego-based Veridiam...
(Date:11/20/2009)...e-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nas...Circuit Court of Appeals reversed a U.S. District ...o pursue all of its claims against The Lash Group,...rial. CTI filed a complaint against The Lash Grou...nt for CTI,s product TRISENOX, in 2007 seeking $22...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
...CF) is caused by mutations in the gene responsible...rstanding the disease-causing mechanisms and devel...of a good animal model; e.g., CF mice fail to deve... However, two independent reports in the April iss...escribed the first steps toward developing large a...
...ndreon Corporation,(Nasdaq: DNDN ) will release i...arch 13, 2008. Company management will host a conf...ew fiscal year 2007 financial results,and provide ...may be,obtained as follows:, Time: 11:00 AM...in: 1-877-548-7901 (domestic) or +1-719-325-4844 ...
...Newswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX... today reported its,financial results for the year...ductive year to date, marking a significant,expans...OLYSIN(R) with,Phase II studies and combination dr...said Dr. Brad Thompson, President and CEO of Oncol...
Other Biology Technology:-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET- 2Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 2Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 3Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 4Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 5Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 6Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 7Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 8Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 9
(Date:11/22/2009)...osed prenatally to tobacco smoke and during childh..., according to research done at Cincinnati Childre...es that up to 35 percent of ADHD cases in children...eliminating both of these environmental exposures.... , "Tobacco and lead exposure each have their ow...
(Date:11/22/2009)...r 18, 2009 -- A butterfly,s proboscis looks like a...ut it works more like a paper towel, according to ...to borrow the tricks of this piece of insect anato...inside of cells. , Kornev will present his work ...an Physical Society,s (APS) Division of Fluid Dyna...
(Date:11/20/2009)...work on many scientific and technological frontier...ovided support that totals nearly $4.3 million for...s under the American Recovery and Reinvestment Act... grants for investigation of solar phenomena. Phil...ill enhance the capabilities of NJIT,s Big Bear So...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2MSU researchers receive 24400 000 in first wave of stimulus funding 8726 1MSU researchers receive 24400 000 in first wave of stimulus funding 8726 2Study 3A Illegal fishing harming present and future New England groundfish fisheries 8724 1Study 3A Illegal fishing harming present and future New England groundfish fisheries 8724 2Scientists examine perceptions of risk and the spread of disease 8722 1Scientists examine perceptions of risk and the spread of disease 8722 2
...announced today its plans to launch a new cancer v...thousands of women with advanced stage ovarian can...Cancer Treatment Centers of America and developed ..., "Cancer Treatment Centers of America,s number on...against cancer," said Dr. Edgar Staren, Chief Medi...
... by Dr Amanda Hayes and her UNSW colleagues, Shahn... cells to airborne toxicants and measures cytotoxi...er membrane inside a small diffusion chamber and t...r as little as one hour,s exposure, they can study...e toxicological endpoints. , Importantly, the tox...
...e more ill-tempered than others? University of Pit... as anger, hostility and aggression may be genetic...e. Indrani Halder, Ph.D., of the Cardiovascular Be...tsburgh, will present the findings today at the Am...d in Budapest, Hungary. , Previous studies have ...
Other Biology News:Soft-cell approach cuts animal tests 2Soft-cell approach cuts animal tests 3
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...hite solid. PACKAGED UNDER INERT GAS. DO NOT FREEZ... with applications similar to those of DTT itself ...ith the important advantage that no soluble compon...eagent can be used in a batch technique, in which ...
... $6.00 and ``silver`` (along with a few other non-...crotomy of a paraffin block, staining, coverslippi...for senile plaques) ,Bodian`s Stain ,Copper St...`s Stain for ameba ,Grimelius Argyrophil Stain (...
...er-friendliness and absolute reliability united wi... the Mastercycler ep system. In the past few years...ally. The same applies to the capabilities require...ogical advances, the challenges of tomorrow must b...
Biology Products: